[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Kaken Pharmaceutical Co. Ltd.](/topic/$4521t)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:"  
[X Link](https://x.com/BiotechTV/status/1953537900907294759) [@BiotechTV](/creator/x/BiotechTV) 2025-08-07T19:25Z 9438 followers, 1832 engagements


"Alumis lead candidate ESK-001 is a potential best-in-class allosteric TYK2 inhibitor for immune-mediated diseases like plaque psoriasis and SLE. Just last month Kaken Pharmaceutical inked a $40M+ licensing deal for rights in Japanunderscoring confidence in this promising next-generation TYK2 inhibitor. Read more:"  
[X Link](https://x.com/drughunter_com/status/1920138003516690463) [@drughunter_com](/creator/x/drughunter_com) 2025-05-07T15:25Z 10.7K followers, 6383 engagements


"$ALMS Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan"  
[X Link](https://x.com/AskEdgarIO/status/1904514065466012131) [@AskEdgarIO](/creator/x/AskEdgarIO) 2025-03-25T12:41Z 2303 followers, XXX engagements